Ascendis Health (JSE:ASC) Long-Term Debt : R3 Mil (As of Jun. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health Long-Term Debt?

Ascendis Health's Long-Term Debt for the quarter that ended in Jun. 2023 was R3 Mil.

Ascendis Health's quarterly Long-Term Debt declined from Jun. 2022 (R22 Mil) to Dec. 2022 (R4 Mil) and declined from Dec. 2022 (R4 Mil) to Jun. 2023 (R3 Mil).

Ascendis Health's annual Long-Term Debt increased from Jun. 2021 (R8 Mil) to Jun. 2022 (R22 Mil) but then declined from Jun. 2022 (R22 Mil) to Jun. 2023 (R3 Mil).

Ascendis Health Long-Term Debt Historical Data

The historical data trend for Ascendis Health's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Health Long-Term Debt Chart

Ascendis Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Long-Term Debt

Get a 7-Day Free Trial

208.23

6,285.09

8.22

22.13

3.43

Ascendis Health Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Long-Term Debt	Get a 7-Day Free Trial															8.22	18.27	22.13	4.16	3.43

Ascendis Health (JSE:ASC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Ascendis Health Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Ascendis Health's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Health (JSE:ASC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090

Website

https://www.ascendishealth.com

Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.